SweetValueLab
Write for us

Dow Inc. — Wall Street Analyst Estimates & Price Targets

DOW
NYSEBasic MaterialsChemicalsCIK 0001751788dow.comAbout DOW
Last close · Oct 16, 202629.93+0.27 (+0.91%)
Market cap$21.6B

5 firms' latest targets, last 90 days: median $32.00 ($30.00–$39.00), 7% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$20.0$30.0$40.0$50.0NovJan 2026MarMayJulSep2025-10-17 · Goldman Sachs: $24.02025-10-24 · RBC Capital: $27.02025-10-24 · UBS: $25.02025-10-24 · Mizuho Securities: $25.02025-10-29 · Goldman Sachs: $27.02025-12-18 · Deutsche Bank: $25.02025-12-23 · UBS: $23.02026-01-08 · Mizuho Securities: $27.02026-01-16 · RBC Capital: $29.02026-01-30 · UBS: $28.02026-01-30 · Jefferies: $28.02026-03-04 · KeyBanc: $38.02026-03-09 · Fermium Research: $38.02026-03-09 · Vertical Research: $37.02026-03-09 · RBC Capital: $40.02026-03-26 · UBS: $40.02026-04-09 · Alembic Global: $50.02026-04-10 · RBC Capital: $47.02026-04-21 · Morgan Stanley: $41.02026-04-24 · UBS: $39.02026-04-24 · BMO Capital: $46.02026-04-27 · Deutsche Bank: $40.02026-04-27 · RBC Capital: $51.02026-06-05 · UBS: $37.02026-07-01 · Mizuho Securities: $35.02026-07-01 · RBC Capital: $28.02026-07-02 · Alembic Global: $45.02026-07-03 · Wells Fargo: $35.02026-07-06 · BMO Capital: $33.02026-07-16 · Goldman Sachs: $34.02026-07-20 · Morgan Stanley: $39.02026-07-24 · UBS: $32.02026-09-17 · Deutsche Bank: $32.02026-09-25 · UBS: $30.02026-10-01 · Mizuho Securities: $32.02026-10-12 · Barclays: $30.0
$20.0$30.0$40.0$50.0NovFebMayAug

Each firm's latest target

last 90 days · 5 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-12Barclays$30.00——+7%+0%
2026-10-01Mizuho Securities$32.00$35.00▼ 9%+16%+7%
2026-09-25UBS$30.00$32.00▼ 6%+7%+0%
2026-09-17Deutsche Bank$32.00$40.00▼ 20%+9%+7%
2026-07-20Morgan Stanley$39.00$41.00▼ 5%+30%+30%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2021reported$55.0B+43%$8.38+411%est. $54.8B+0%est. $8.866
2022reported$56.9B+4%$6.28-25%est. $57.1B+0%est. $6.405
2023reported$44.6B-22%$0.82-87%est. $44.4B+1%est. $2.2113
2024reported$43.0B-4%$1.57+91%est. $43.1B+0%est. $1.9610
2025reported$40.0B-7%-$3.70-336%est. $40.0B+0%est. -$1.0410
2026$43.7B+9%$2.38—$43.4B–$43.9B$2.18–$2.6812
2027$42.6B-3%$1.56-34%$41.3B–$44.9B$0.54–$2.2513
2028$43.7B+3%$1.68+7%$39.6B–$46.9B$1.34–$1.9012
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.